CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-29 | GILEAD SCIENCES, INC. 10% owner | Purchase | +15,238,095 | $21.00 | $320.0M | 30,061,124 |
| 2024-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +22,000 | 73,831 | ||
| 2024-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award | +21,300 | 73,131 | ||
| 2024-01-23 | Goeltz II Robert C. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +86,600 | 86,600 | ||
| 2024-01-23 | Jaen Juan C. President | Grant or award | +40,000 | 341,475 | ||
| 2024-01-23 | Jaen Juan C. President | Grant or award · Stock Option (right to buy) | +162,400 | 162,400 | ||
| 2024-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award | +8,850 | 19,070 | ||
| 2024-01-23 | Azoy Alexander Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +5,900 | 5,900 | ||
| 2024-01-23 | Tang Carolyn C. General Counsel | Grant or award | +26,700 | 114,579 | ||
| 2024-01-23 | Tang Carolyn C. General Counsel | Grant or award · Stock Option (right to buy) | +108,200 | 108,200 | ||
| 2024-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +100,000 | 3,966,974 | ||
| 2024-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +405,900 | 405,900 | ||
| 2024-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award | +40,000 | 298,878 | ||
| 2024-01-23 | Jarrett Jennifer Chief Operating Officer | Grant or award · Stock Option (right to buy) | +162,400 | 162,400 | ||
| 2024-01-23 | Nuyten Dimitry SA Chief Medical Officer | Grant or award | +28,000 | 99,195 | ||
| 2024-01-23 | Nuyten Dimitry SA Chief Medical Officer | Grant or award · Stock Option (right to buy) | +113,700 | 113,700 | ||
| 2024-01-02 | Goeltz II Robert C. Chief Financial Officer | Sale 10b5-1 | −2,004 | $20.00 | $40K | 51,831 |
Page 9 of 9 · 177 trades